Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) (“Nanobac” or “the Company”) today announced that its scientists have obtained new details about interactions of drugs with calcifying nanoparticles (CNPs), known also as nanobacteria, using award-winning light microscope technology.